Vaxart, Inc. (VXRT)

Vaxart Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-58.12	-66.95	-82.47	-107.76	-70.47	-32.22
Depreciation & Amortization	8.92	8.85	8.62	5.81	4.21	2.71
Loss (Gain) From Sale of Assets	-	-	0.06	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	4.25	3.01	-
Loss (Gain) From Sale of Investments	-0.79	-0.76	-0.66	-0.16	0.09	-
Stock-Based Compensation	9.84	11.5	14.13	13.59	8.87	4.36
Other Operating Activities	-0.49	-0.67	0.71	-5.81	-3.41	-1.4
Change in Accounts Receivable	-7.15	-8.96	-2.99	0.05	0.26	3.29
Change in Accounts Payable	12.72	5.27	-2.44	0.36	1.63	1.21
Change in Unearned Revenue	56.94	65.4	-2	2	-	-
Change in Other Net Operating Assets	-55.04	-58.45	-3.42	-7.11	-4.01	-1.69
Operating Cash Flow	-33.17	-44.76	-70.45	-94.78	-59.83	-23.75
Capital Expenditures	-0.55	-0.55	-1.87	-9.6	-5.16	-1.22
Sale of Property, Plant & Equipment	-	-	0.12	-	-	0
Cash Acquisitions	-	-	-	-	-4.83	-
Investment in Securities	-2.52	-20.77	45.7	-10.81	-39.11	-
Investing Cash Flow	-3.07	-21.32	43.95	-20.42	-49.1	-1.22
Issuance of Common Stock	41.16	59.53	16	18.25	131.56	141.45
Repurchase of Common Stock	-0.2	-0.21	-0.37	-	-	-
Other Financing Activities	-2.76	-2.76	-0.39	-0.79	-5.75	-3.14
Financing Cash Flow	38.2	56.56	15.24	17.46	125.8	138.31
Net Cash Flow	1.96	-9.53	-11.26	-97.73	16.88	113.34
Free Cash Flow	-33.73	-45.32	-72.32	-104.38	-64.99	-24.97
Free Cash Flow Margin	-71.16%	-157.90%	-980.13%	-97551.40%	-7285.76%	-617.23%
Free Cash Flow Per Share	-0.15	-0.22	-0.50	-0.82	-0.54	-0.28
Levered Free Cash Flow	50.39	42.32	-40.58	-56.37	-35.61	-10.79
Unlevered Free Cash Flow	52.37	44.17	-39.68	-55.56	-34.69	-9.62
Change in Net Working Capital	-69.88	-65.81	8.47	-3.61	-0.99	-3.93

Source: S&P Global Market Intelligence. Standard template. Financial Sources.